arrow_back Back Filing freshness 10-K Q4 FY2026 SEC EDGAR

PETMED EXPRESS INC

PETS
$1.99 ▲ +0.02 (+1.02%) at close
Healthcare ·Retail-Drug Stores and Proprietary Stores ·USRetail-Drug Stores and Proprietary Stores
66 Visible periods
30 Metrics
Peer-ranked Benchmarks
Price Chart
9
Health
Poor
Bearish
auto_awesome

Analytical Summary

PETMED EXPRESS INC faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap
Dividend Yield
Revenue Growth -15.6%
Op. Margin -13.3%
ROIC -19.2%
FCF / Share None
Trailing P/E
Price / Book 1.5x
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

66-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$42.82M
↓ -15.6%
Net Income Profit after all expenses
$-4.06M
↑ +65.1%
Operating Margin Operating profit as % of sales
-13.3%
↑ +48.4% 2th
FCF / Share Free cash flow per share
$-0.44
↓ -91.2%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability
4
Returns
2
Cash Quality
39

Dividend History

Dividend / share · sourced from SEC filings
$0.00 Latest / share

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 18 years · 66 quarters